Equitable Holdings »

Humacyte shares owned by Equitable Holdings

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Equitable Holdings from 13F filings

Historical chart of Equitable Holdings investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Equitable Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Equitable Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 15k 0.96
2025-09-30 $29k 17k 1.74

More positions owned by Equitable Holdings

Spdr Series Trust State Street Spd (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Spdr Series Trust State Street Spd (SPYV)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Morningstar Grwt (ILCG)
Vanguard World Inf Tech Etf (VGT)
Apple (AAPL)
Ishares Tr Expnd Tec Sc Etf (IGM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Equitable Holdings

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
State Street Corporation
Woodline Partners
Susquehanna International
Two Sigma Investments
Charles Schwab Investment Management
Northern Trust
Millennium Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
LPL Financial
Barclays

View all funds holding Humacyte